Jeffrey Kindler, the CEO of Pfizer, the world's largest drug-maker, has unexpectedly quit, citing the "incredibly demanding" nature of his job. Although Pfizer suffered mixed fortunes during Kindler's four-plus year tenure and its stock price has slipped by 35 percent, the sudden nature of Kindler's departure has commentators speculating what prompted his exit:
He was exhausted: Running Pfizer "doesn't sound like fun," says Tracy Corrigan at The Daily Telegraph, and "Kindler, to his credit, has been honest enough to say so." Saying his job was "extremely demanding" on a personal level is as close to straight talk as any "statement rewritten by corporate PR advisers can be." I call that a "touchingly human and unpretentious" move.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
6 scenic white water rafting destinations to get your heart racingThe Week Recommends Have a rip-roaring time on the water
-
Dangerous substances in Lunchables are raising concerns over children's healthIn the Spotlight High levels of lead and sodium were recently found in the snack packages
-
The Week contest: Fired artPuzzles and Quizzes
